Application deadline on 31 August 2022
Despite decades with significant efforts in gene sequencing, there is a large medical need for better markers that can predict outcomes to improve personal medicine and increase likelihood of success in drug development. Digital pathology and deep learning are on the verge of a breakthrough in medicine and can meet this need. DoMore Diagnostics is uniquely positioned with protected and scalable technology based on top notch research, and being the first company to obtain CE Mark for a prognostic digital marker.
Kipuwex is an easy-to-use light-weight IoT device which wirelessly, continuously, and digitally measures a plurality of clinically relevant physiological parameters vital to the assessment of human well-being and disease management. The physiological parameters can be monitored remotely anywhere, at any time, by health care professionals and home users with a mobile or web application. Kipuwex then converts physiological parameters with an algorithm into reliable measurements for healthcare professionals and home users.
We are creating breakthroughs in diagnostic device development, utilising a re-usable detection technology with a positive impact on both the environment and the end-user. Our initial focus is on upgrading the pregnancy test through the development of a reusable test device that is easy to interpret, hygienic to use, and 99% accurate at the day of expected menstruation. In turn, this increases convenience-levels, reduces customer spendings on their reproductive health, minimises the risk of misinterpreting the test results, and is beneficial for the environment.